Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients

The goal of this clinical trial is to know if stevia leave powder capsule (1000 mg/day) will work to treat diabetes in participants. The main objectives it aims to answer are: Does stevia decrease the blood glucose level in diabetic subjects that will use stevia powder capsule? Does stevia play its role in blood lipid profile in diabetic subjects that will use stevia powder capsule? The purpose of the study to see the impact of stevia in short (7 days) and long-term treatments (60 days) in diabetic subjects and compare the results Diabetic subjects will: Take stevia powder capsule every day for 7 days in short term study Take stevia powder capsule every day for 60 days in long term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 7th days in short term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 30 and 60th days in long term study Keep a record of all the tests for comparison

NCT Number	NCT06645002
Lead Sponsor	University of Lahore Collaborators: Allied Hospital Faisalabad
Conditions	Diabetes
Enrollment	144 participants
Start Date	2024-08-22
Primary Completion	2024-11-22 (estimated)
Study Completion	2025-02-22 (estimated)
Updated on ClinicalTrials.gov	2024-10-16